By InvitationNot Applicable

HF Tissue Registry

200 participantsStarted 2008-06

Plain-language summary

This is a registry study. This is an observational, non-randomized, open, long-term project to collect biological samples (e.g. tissue and blood samples) in addition to clinical information and laboratory test results, from end-stage patients who undergo LVAD implantation and/or heart transplantation. There are no investigational treatments, drug or procedures associated with participation in registry activities. Data collection will not immediately influence the course of treatment for any patient.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients must be in one of the following groups:
✓.1. Patients must be eligible for a -
✓.3. Patients must have a VAD already implanted as destination therapy with no cardiac surgery scheduled at the time of consent.
✓. Patients must agree to one or more blood and/or cardiac tissue sample donation(s), and longterm storage of these biological samples.
✓. Patients must be \> 18 years of age.

Exclusion criteria

✕. The patient or the patient's personal representative is unable or unwilling to give written informed consent for participation.
✕. Patients who are less than 18 years of age.

What they're measuring

All cause mortality

Timeframe: 20 years

Trial details

NCT IDNCT02683681

SponsorIntermountain Health Care, Inc.

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2036-12-31

View on ClinicalTrials.gov More Heart Failure trials